>
Switch to:

Allergy Therapeutics Pre-Tax Income

: $4.2 Mil (TTM As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

Pretax income is the income that a company earns before paying income taxes. Allergy Therapeutics's pretax income for the six months ended in Jun. 2021 was $-16.7 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2021 was $4.2 Mil. Allergy Therapeutics's pretax margin was -39.33%.

During the past 13 years, Allergy Therapeutics's highest Pretax Margin was 10.32%. The lowest was -24.87%. And the median was 1.53%.


Allergy Therapeutics Pre-Tax Income Historical Data

The historical data trend for Allergy Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Pre-Tax Income
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.52 -9.17 5.44 10.10 5.13

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Pre-Tax Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.16 20.78 -9.74 20.93 -16.71

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics Pre-Tax Income Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Pre-Tax Income falls into.



Allergy Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Allergy Therapeutics's Pretax Income for the fiscal year that ended in Jun. 2021 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=5.6535764375877+0+-0.68863955119215+0.15007012622721+0.014025245441796
=5.1

Allergy Therapeutics's Pretax Income for the quarter that ended in Jun. 2021 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-16.476858345021+0+-0.3492286115007+0.099579242636746+0.014025245441797
=-16.7

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (OTCPK:AGYTF) Pre-Tax Income Explanation

Allergy Therapeutics's Pretax Margin for the quarter that ended in Jun. 2021 is calculated as

Pretax Margin=Pretax Income/Revenue
=-16.712482468443/42.495091164095
=-39.33%

During the past 13 years, Allergy Therapeutics's highest Pretax Margin was 10.32%. The lowest was -24.87%. And the median was 1.53%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)